Taylor Morrison (TMHC) Files Form 144 for 50,000-Share Sale

Rhea-AI Filing Summary

Taylor Morrison Home Corporation (TMHC) submitted a Form 144 reporting a proposed sale of 50,000 shares of common stock through J.P. Morgan Securities LLC on 08/22/2025. The filing states these shares were acquired on 02/26/2024 upon vesting of Performance Restricted Stock Unit awards from the issuer. The filing lists an aggregate market value of $3,291,000 and notes approximately 98,843,205 shares outstanding, indicating the planned sale represents a small fraction of total shares. The filer certifies no undisclosed material adverse information and reports no other sales in the prior three months.

Positive

• Full disclosure of transaction details including broker, acquisition date, and nature of acquisition (vesting of PRSUs)
• Filer certifies no undisclosed material adverse information, supporting transparency
• No other sales in the prior three months, simplifying Rule 144 aggregation

Negative

• Insider sale of vested equity may be perceived negatively by some investors despite being routine
• Aggregate market value of $3.29 million is non-trivial in absolute terms, though small versus total outstanding shares

Insights

Securities Analyst

TL;DR: Routine insider sale of vested equity, limited size relative to outstanding shares, so likely neutral for valuation.

The filing documents a planned sale of 50,000 vested shares by a person associated with TMHC. Because the shares arose from the vesting of PRSUs, this appears to be realization of compensation rather than a secondary private transfer. The aggregate value reported is $3.29 million which, while not trivial in absolute terms, represents roughly 0.05% of the stated outstanding share count, suggesting limited direct market impact. The filer also affirms no undisclosed material adverse information and reports no sales in the last three months, which supports the view this is a routine disclosed transaction.

Corporate Governance Specialist

TL;DR: Document reflects standard Rule 144 compliance for an executive or insider monetizing vested awards, consistent with disclosure expectations.

The Form 144 provides required broker, timing, acquisition and payment details: acquisition date 02/26/2024, nature of acquisition vesting of PRSUs, broker J.P. Morgan Securities LLC, and planned sale date 08/22/2025. The absence of other sales in the recent three-month window simplifies aggregation calculations under Rule 144. From a governance perspective, the filing meets procedural disclosure obligations and includes the standard representation about material adverse information, which helps preserve market transparency around insider sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 390 Madison Avenue, 6th Floor New York NY 10017	50000	3291000	98843205	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/26/2024	Vesting of Performance Restricted Stock Unit Awards	Issuer			50000	02/26/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does TMHC's Form 144 report?

It reports a proposed sale of 50,000 shares of TMHC common stock to be executed through J.P. Morgan Securities LLC on 08/22/2025.

How were the shares acquired?

The shares were acquired on 02/26/2024 upon vesting of Performance Restricted Stock Unit awards granted by the issuer.

What is the reported aggregate market value and outstanding shares?

The filing lists an aggregate market value of $3,291,000 and approximately 98,843,205 shares outstanding.

Has the filer sold other TMHC shares in the past three months?

The Form 144 states "Nothing to Report" for securities sold during the past three months.

Does the filing include any material adverse information about TMHC?

The filer represents by signature that they do not know of any material adverse information about the issuer that is not publicly disclosed.